Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT3A | Q9Y6K1 | 5/20 | 0.51 |
| ▸ | EHMT2 | Q96KQ7 | 7/20 | 0.48 |
| ▸ | MCHR1 | Q99705 | 4/20 | 0.41 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | HRH1 | P35367 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | NSD2 | O96028 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4766829 | 1.00 | DNMT3A (0.51) | DNMT3AEHMT2MCHR1PDE1BCHRM1 | |
| Hydrochloric Acid SCHEMBL4124628 | 0.99 | DNMT3A (0.50) | DNMT3AEHMT2MCHR1PDE1BCHRM1 | |
| Hydrochloric Acid SCHEMBL4116576 | 0.99 | DNMT3A (0.50) | DNMT3AEHMT2MCHR1PDE1BCHRM1 | |
| SCHEMBL4722724 | 0.89 | DNMT3A (0.52) | DNMT3AEHMT2MCHR1MEN1KMT2A | |
| SCHEMBL4767693 | 0.89 | DNMT3A (0.52) | DNMT3AEHMT2MCHR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4117292 | 0.88 | DNMT3A (0.51) | DNMT3AEHMT2MCHR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4125413 | 0.88 | DNMT3A (0.51) | DNMT3AEHMT2MCHR1MEN1KMT2A | |
| SCHEMBL13850463 | 0.88 | DNMT3A (0.56) | DNMT3AEHMT2MCHR1MEN1KMT2A | |
| SCHEMBL4765739 | 0.87 | DNMT3A (0.55) | DNMT3AEHMT2MCHR1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4116749 | 0.86 | DNMT3A (0.55) | DNMT3AEHMT2MCHR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1940823-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2008-07-09 | — | — | EP | claimed |
| WO-2007042660-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-04-19 | — | — | WO | claimed |
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2009-05-14 | — | — | US | disclosed |
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | SANOFI-AVENTIS (FR) | 2009-05-14 | — | — | US | disclosed |
| EP-1940823-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2008-07-09 | — | — | EP | disclosed |
| WO-2007042660-A2 | SUBSTITUTED 1-AMINO-PHTHALZINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124624-A1 | SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF | AGTR1, AGTR2, AHR | DNMT3A 3277/4885EHMT2 993/4885MCHR1 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.